Form 4: Lilly Endowment Inc. Sells $17.8 Million in Eli Lilly & Co. Stock
SEC Form 4
Lilly Endowment Inc., a major shareholder of Eli Lilly & Co., reports selling 96,119 shares of LLY common stock on February 6, 2025, at prices ranging from $866.067 to $887.316.
Summary
- On February 6, 2025, Lilly Endowment Inc. sold 96,119 shares of Eli Lilly & Co. (LLY) common stock.
- The sales were executed in multiple transactions with prices ranging from $866.067 to $887.316 per share.
- The total value of the shares sold is approximately $84 million.
- Following these transactions, Lilly Endowment Inc. still beneficially owns 96,681,978 shares of Eli Lilly & Co.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock sales. The sentiment is neither positive nor negative as it simply reflects a transaction.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell the company's stock. This filing indicates a change in Lilly Endowment Inc.'s holdings in Eli Lilly & Co.
Key Dates
| Date | Description |
|---|---|
| 02/06/2025 | Date of the stock sale transactions. |
| 02/07/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.